1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Antacids Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Antacids Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. North America Antacids Market Regional Analysis
6.1 North America Antacids Market Overview
6.2 North America Antacids Market Revenue 2017-2027 (US$ Million)
6.3 North America Antacids Market Forecast Analysis
7. North America Antacids Market Analysis – by Dosage Form
7.1 Tablet
- 7.1.1 Overview
- 7.1.2 Tablet: North America Antacids Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Liquid
- 7.2.1 Overview
- 7.2.2 Liquid: North America Antacids Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Antacids Market Analysis – by Drug Class
8.1 Proton Pump Inhibitors
- 8.1.1 Overview
- 8.1.2 Proton Pump Inhibitors: North America Antacids Market – Revenue and Forecast to 2027 (US$ Million)
8.2 H2 Antagonist
- 8.2.1 Overview
- 8.2.2 H2 Antagonist: North America Antacids Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Acid Neutralizers
- 8.3.1 Overview
- 8.3.2 Acid Neutralizers: North America Antacids Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Antacids Market Analysis – by Distribution Channel
9.1 Hospital Pharmacy
- 9.1.1 Overview
- 9.1.2 Acid Neutralizers: North America Antacids Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Retail Pharmacy
- 9.2.1 Overview
- 9.2.2 Acid Neutralizers: North America Antacids Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Online Pharmacy
- 9.3.1 Overview
- 9.3.2 Acid Neutralizers: North America Antacids Market – Revenue and Forecast to 2027 (US$ Million)
10. North America Antacids Market – North America Analysis
10.1 North America
- 10.1.1 North America Antacids Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.1.1.1 North America Antacids Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Antacids Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 US: North America Antacids Market Breakdown, by Dosage Form
- 10.1.1.1.2 US: North America Antacids Market Breakdown, by Drug Class
- 10.1.1.1.3 US: North America Antacids Market Breakdown, by Distribution Channel
- 10.1.1.2 Canada:
North America Antacids Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Canada: North America Antacids Market Breakdown, by Dosage Form
- 10.1.1.2.2 Canada: North America Antacids Market Breakdown, by Drug Class
- 10.1.1.2.3 Canada: North America Antacids Market Breakdown, by Distribution Channel
- 10.1.1.3 Mexico :
North America Antacids Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 Mexico : North America Antacids Market Breakdown, by Dosage Form
- 10.1.1.3.2 Mexico : North America Antacids Market Breakdown, by Drug Class
- 10.1.1.3.3 Mexico : North America Antacids Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Antacids Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Bayer AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 GlaxoSmithKline plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Takeda Pharmaceutical Company Limited
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Sun Pharmaceutical Industries Ltd
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Sanofi
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Boehringer Ingelheim International GmbH
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Dr. Reddy's Laboratories
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Pfizer Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Reckitt Benckiser Group Plc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Procter & Gamble
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Antacids Market
